Effects of Insulin Glargine and Liraglutide Therapy on Liver Fat as Measured by Magnetic Resonance in Patients With Type 2 Diabetes: A Randomized Trial.

An TangRémi Rabasa-LhoretHélène CastelClaire Wartelle-BladouGuillaume GilbertKarine Massicotte-TisluckGabriel ChartrandDamien OliviéAnne-Sophie JulienJacques de GuiseGilles SoulezJean-Louis Chiasson

Published in: Diabetes care (2015)

The administration of insulin glargine therapy reduced the liver fat burden in patients with type 2 diabetes. However, the improvements in the liver fat fraction and glycemia control were not significantly different from those in the liraglutide group.

Keyphrases

magnetic resonance
adipose tissue
glycemic control
type diabetes
fatty acid
stem cells
magnetic resonance imaging
insulin resistance
computed tomography
risk factors
weight loss
skeletal muscle
mesenchymal stem cells
contrast enhanced
replacement therapy